πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 591 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11787840

Compositions and methods for treating and preventing autoimmune induced cardiac long QT sy

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11771739

Methods and compositions for treating microbial inflammation

THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS Β· Granted Tue Oct 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11766403

Peptide-targeted liposomal delivery for treatment, diagnosis, and imaging of diseases and

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Sep 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11760789

Broadly neutralizing antibodies against HIV

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11752220

Method of delivering genes and drugs to a posterior segment of an eye

The United States Government as Represented by the Department of Veterans Affair Β· Granted Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11744831

Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infec

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11730799

Cancer vaccines and methods of producing and using same

THE UNITED STATES GOVERNMENT DEPARTMENT OF VETERANS AFFAIRS Β· Granted Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11730705

Small molecule CMKLR1 antagonists in inflammatory disease

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11725217

Methods to enhance myocardial regeneration and/or repair

Regents of the University of Minnesota Β· Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11707459

Method for treating nervous system injuries using boldine and analogs thereof

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jul 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11696903

Compounds and methods for scavenging dicarbonyl electrophiles

THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS Β· Granted Tue Jul 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11690895

Compositions and methods of interferon alpha binding proteins

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11679121

Morpholino oligonucleotides useful in cancer treatment

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11680079

Nucleic acid aptamers to treat histone-induced disease states

The United States Government as Represented by The Department of Veteran Affairs Β· Granted Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11672801

Compositions and methods for treating cancer

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11672811

Materials and methods for suppressing and/or treating bone related diseases and symptoms

The United States of America as Represented by the Department of Veteranas Affairs Β· Granted Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11673853

Small molecule AMPK activators

THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS Β· Granted Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11643656

Antisense therapies for treating cancer

The United States Government represented by the Department of Veterans Affairs Β· Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11643394

KrΓΌppel-like factor 15 (KLF15) small molecule agonists in kidney disease

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11639364

Potent sialyltransferase inhibitors

Stichting Radboud universitair medisch centrum Β· Granted Tue May 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11633511

Production of immune-response-stimulating aerosols by non-thermal plasma treatment of airb

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Apr 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11623918

Compounds for the treatment of acute and chronic kidney disease

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11612663

Proteoglycan mimetics for enhanced wound healing, angiogenesis, and vascular repair

The Regents of the University of California Β· Granted Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11612580

Compositions for inhibiting 3β€² repair exonuclease 2 and methods of screening for such comp

The Board of Regents of the University of Texas System Β· Granted Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted